free porn
porn
free porn

Agenda

AgendaARM’s Advanced Therapies Investor Day is a full-day meeting comprised of discussions between key opinion leaders, top analysts and senior executives with presentations by the field’s most promising companies.

More details on the speakers for the 2017 meeting will be released soon so please check back!

2017 Preliminary Agenda

7:30am REGISTRATION, BREAKFAST & NETWORKING
8:00am WELCOME REMARKS
Speaker:
Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine (ARM)
8:15am FIRESIDE CHAT: IMMUNO-ONCOLOGY
Chair:
Keith Thompson, CEO, Cell and Gene Therapy Catapult
8:45am FIRESIDE CHAT: GENE THERAPY
9:15am PANEL: HEALTH TECHNOLOGY ASSESSMENT AND ACCESS FOR ATMPs
Speakers:
Eric Faulkner, VP, Precision and Transformative Technology Solutions, Value Demonstration, Access and Commercial, Evidera
Diane Kleinermans, Advisor, Ministry of Health and Social Affairs Belgium; Expert to the Commission of Drugs Reimbursement, National Institute for Health and Disability Insurance (NIHDI)
Pilar Pinilla-Dominguez, Technical Adviser, National Institute for Health and Care Excellence (NICE)
Holger Raffel, Contract Manager, DAK Gesundheit; CEO, HRaffel Consulting
10:15am MORNING BREAK
10:30am COMPANY PRESENTATIONS
11:15am PANEL: ACCELERATED APPROVAL SCHEMES AND THEIR IMPACT ON ATMP PRODUCTS
Speakers:
Jordi Llinares Garcia, M.D., Head of Scientific and Regulatory Management, European Medicines Agency (EMA)
Rizwana Sproule, Ph.D., VP, Regulatory Affairs, Kite Pharma
12:15pm LUNCH & NETWORKING
1:30pm COMPANY PRESENTATIONS
2:30pm PANEL: ACCESS TO CAPITAL: FINANCING OPPORTUNITIES FOR ATMP COMPANIES
Speaker:
Chris Hollowood, Chief Investment Officer and Managing Partner, Syncona
3:30pm AFTERNOON BREAK
3:45pm COMPANY PRESENTATIONS
5:00pm NETWORKING RECEPTION
6:30pm PROGRAM CLOSE